Cardio Diagnostics (CDIO)
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a thr...
- Open
- 1.810
- High
- 1.890
- Low
- 1.810
- Prev. Close
- 1.850
- Volume
- 11.76K
- Turnover
- 21.85K
- Avg Price
- 1.858
- Bid/Ask Ratio
- -33.33%
- Amplitude
- 4.32%
- 52wk High
- 7.910
- Volume Ratio
- 0.06
- Turnover Ratio
- 0.41%
Cardio Diagnostics Analyst Rating
View moreForecast & Rating
Jan 24, 2025Price forecast
$60.003178.69%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Aug 26 at 12:35 PM
Cardio Diagnostics report flags widening rural cardiovascular care gap as workforce shortages persist
- StockTitan · Aug 26 at 04:35 AM
Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges | CDIO Stock News
- PUBT · Aug 18 at 12:35 PM
Cardio Diagnostics wins federal CLIA license for high-complexity Iowa City lab
- StockTitan · Aug 18 at 04:35 AM
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City | CDIO Stock News
- Price Alert · Aug 13 at 09:23 AM
Pre-market hot trades in US stocks: Cardio Diagnostics up 7.98% in pre-market; Ondas up 6.73% in pre-market
- Price Alert · Aug 12 at 05:38 PM
U.S. Stock Market Midday Update: CDIO Rises 13.11% Without Positive News? Capital Inflows Drive Volatility
